Business Description
Argenica Therapeutics Ltd
ISIN : AU0000150328
Share Class Description:
ASX:AGN: Ordinary SharesDescription
Argenica Therapeutics Ltd is engaged in the development and commercialization of novel drug candidates. Its ARG007 drug improves outcomes in pre-clinical stroke models and is in the process of being verified for its safety and toxicology before commencing Phase 1 clinical trials in humans.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.77 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 57.9 | |||||
| 9-Day RSI | 56.15 | |||||
| 14-Day RSI | 53.72 | |||||
| 6-1 Month Momentum % | 69.33 | |||||
| 12-1 Month Momentum % | 51.19 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.25 | |||||
| Quick Ratio | 4.25 | |||||
| Cash Ratio | 4.16 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -5.41 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -66.1 | |||||
| ROA % | -53.02 | |||||
| ROIC % | -1445.56 | |||||
| ROCE % | -66.06 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 8.81 | |||||
| Price-to-Tangible-Book | 8.79 | |||||
| EV-to-EBIT | -13.72 | |||||
| EV-to-EBITDA | -13.72 | |||||
| EV-to-FCF | -17.68 | |||||
| Price-to-Net-Current-Asset-Value | 8.79 | |||||
| Price-to-Net-Cash | 10.25 | |||||
| Earnings Yield (Greenblatt) % | -7.3 | |||||
| FCF Yield % | -4.83 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Argenica Therapeutics Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | |||
| EPS (TTM) (A$) | -0.051 | ||
| Beta | 0 | ||
| Volatility % | 53.44 | ||
| 14-Day RSI | 53.72 | ||
| 14-Day ATR (A$) | 0.032357 | ||
| 20-Day SMA (A$) | 0.589 | ||
| 12-1 Month Momentum % | 51.19 | ||
| 52-Week Range (A$) | 0.295 - 0.75 | ||
| Shares Outstanding (Mil) | 122.82 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Argenica Therapeutics Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Argenica Therapeutics Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Argenica Therapeutics Ltd Frequently Asked Questions
What is Argenica Therapeutics Ltd(ASX:AGN)'s stock price today?
The current price of ASX:AGN is A$0.62. The 52 week high of ASX:AGN is A$0.75 and 52 week low is A$0.30.
When is next earnings date of Argenica Therapeutics Ltd(ASX:AGN)?
The next earnings date of Argenica Therapeutics Ltd(ASX:AGN) is .
Does Argenica Therapeutics Ltd(ASX:AGN) pay dividends? If so, how much?
Argenica Therapeutics Ltd(ASX:AGN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers